The University Of Miami School Of Medicine has for the first time initiated treatment of a COVID-19 patient with Bellerophon Therapeutics Inc.'s (BLPH) INOpulse inhaled nitric oxide system under the emergency expanded access program.
from RTT - Before the Bell https://ift.tt/2UtRv3D
via IFTTT
No comments:
Post a Comment